{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:08:20Z","timestamp":1783786100902,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T00:00:00Z","timestamp":1577491200000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sclerosing mucoepidermoid carcinoma with eosinophilia is a rare form of thyroid carcinoma. The underlying molecular mechanisms of sclerosing mucoepidermoid carcinoma with eosinophilia tumorigenesis remain unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present two cases of sclerosing mucoepidermoid carcinoma with eosinophilia, both with a concurrent papillary thyroid carcinoma. Patient 1, a 70-year-old Caucasian woman, presented with sclerosing mucoepidermoid carcinoma with eosinophilia with distant renal metastasis and coexisting papillary thyroid carcinoma. Patient 2, a 74-year-old Caucasian woman with a remote history of thyroid cancer treated with thyroidectomy, presented with locoregionally invasive sclerosing mucoepidermoid carcinoma with eosinophilia and recurrent papillary thyroid carcinoma in the thyroid bed.<jats:italic>BRAF<\/jats:italic>mutation studies were performed on the sclerosing mucoepidermoid carcinoma with eosinophilia tumors. In both cases, sclerosing mucoepidermoid carcinoma with eosinophilia was positive for the<jats:italic>BRAF<\/jats:italic>V600E mutation by polymerase chain reaction. Patient 1 is the first reported case of sclerosing mucoepidermoid carcinoma with eosinophilia with renal metastasis, to the best of our knowledge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings suggest, for the first time, to our knowledge, involvement of the RAS-RAF-MEK-ERK signaling pathway in the pathogenesis of sclerosing mucoepidermoid carcinoma with eosinophilia. Thus, BRAF inhibitors may prove to be a useful targeted medical therapy in the treatment of a subset of patients with aggressive sclerosing mucoepidermoid carcinoma with eosinophilia tumors who exhibit<jats:italic>BRAF<\/jats:italic>activating mutation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-019-2288-0","type":"journal-article","created":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T01:02:22Z","timestamp":1577494942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Activating BRAF mutation in sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: two\u00a0case reports and review of the literature"],"prefix":"10.1186","volume":"13","author":[{"given":"Jasmine S.","family":"Sukumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil","family":"Sukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshana","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Balani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumitha S.","family":"Hathiramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,28]]},"reference":[{"issue":"5","key":"2288_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/00000478-199105000-00003","volume":"15","author":"JK Chan","year":"1991","unstructured":"Chan JK, Albores-Saavedra J, Battifora H, Carcangiu ML, Rosai J. Sclerosing mucoepidermoid thyroid carcinoma with eosinophilia: a distinctive low-grade malignancy arising from the metaplastic follicles of Hashimoto\u2019s thyroiditis. Am J Surg Pathol. 1991;15(5):438\u201348.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2288_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/modpathol.2016.180","volume":"30","author":"AA Shah","year":"2017","unstructured":"Shah AA, La Fortune K, Miller C, Mills SE, Baloch Z, LiVolsi V, et al. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: a clinicopathologic and molecular analysis of a distinct entity. Mod Pathol. 2017;30(3):329\u201339.","journal-title":"Mod Pathol"},{"issue":"7","key":"2288_CR3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/modpathol.3880140","volume":"13","author":"ZW Baloch","year":"2000","unstructured":"Baloch ZW, Solomon AC, LiVolsi VA. Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases. Mod Pathol. 2000;13(7):802\u20137.","journal-title":"Mod Pathol"},{"issue":"5","key":"2288_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.humpath.2015.01.012","volume":"46","author":"G Quiroga-Garza","year":"2015","unstructured":"Quiroga-Garza G, Lee JH, El-Naggar A, Black JO, Amrikachi M, Zhai QJ, et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: more aggressive than previously reported. Hum Pathol. 2015;46(5):725\u201331.","journal-title":"Hum Pathol"},{"issue":"3","key":"2288_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ajcp\/109.3.294","volume":"109","author":"KR Geisinger","year":"1998","unstructured":"Geisinger KR, Steffee CH, McGee RS, Woodruff RD, Buss DH. The cytomorphologic features of sclerosing mucoepidermoid carcinoma of the thyroid gland with eosinophilia. Am J Clin Pathol. 1998;109(3):294\u2013301.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2288_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0196-0709(03)00096-6","volume":"25","author":"NJ Shehadeh","year":"2004","unstructured":"Shehadeh NJ, Vernick J, Lonardo F, Madan SK, Jacobs JR, Yoo GH, et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: a case report and review of the literature. Am J Otolaryngol. 2004;25(1):48\u201353.","journal-title":"Am J Otolaryngol"},{"issue":"9","key":"2288_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0046-8177(97)90064-2","volume":"28","author":"SJ Sim","year":"1997","unstructured":"Sim SJ, Ro JY, Ordonez NG, Cleary KR, Ayala AG. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: report of two patients, one with distant metastasis, and review of the literature. Hum Pathol. 1997;28(9):1091\u20136.","journal-title":"Hum Pathol"},{"issue":"2","key":"2288_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1677\/erc.1.0978","volume":"12","author":"M Xing","year":"2005","unstructured":"Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005;12(2):245\u201362.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2288_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1210\/jc.2009-2332","volume":"95","author":"DW Ball","year":"2010","unstructured":"Ball DW. Selectively targeting mutant BRAF in thyroid cancer. J Clin Endocrinol Metab. 2010;95(1):60\u20131.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2288_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/0046-8177(95)90272-4","volume":"26","author":"Bruce M Wenig","year":"1995","unstructured":"Wenig BM, Adair CF, Heffess CS. Primary mucoepidermoid carcinoma of the thyroid gland: a report of six cases and a review of the literature of a follicular epithelial-derived tumor. Hum Pathol. 1995;26(10):1099\u20131108.","journal-title":"Human Pathology"},{"issue":"4","key":"2288_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/(SICI)1097-0339(199611)15:4<301::AID-DC10>3.0.CO;2-S","volume":"15","author":"L Bondeson","year":"1996","unstructured":"Bondeson L, Bondeson AG. Cytologic features in fine-needle aspirates from a sclerosing mucoepidermoid thyroid carcinoma with eosinophilia. Diagn Cytopathol. 1996;15(4):301\u2013305.","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"2288_CR12","first-page":"31","volume":"91","author":"A Cavazza","year":"1999","unstructured":"Cavazza A, Toschi E, Valcavi R, et al. [Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: description of a case]. Pathologica. 1999;91(1):31\u201335.","journal-title":"Pathologica"},{"issue":"3","key":"2288_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3346\/jkms.1999.14.3.338","volume":"14","author":"J Chung","year":"1999","unstructured":"Chung J, Lee SK, Gong G, et al. Sclerosing Mucoepidermoid carcinoma with eosinophilia of the thyroid glands: a case report with clinical manifestation of recurrent neck mass. J Korean Med Sci. 1999;14(3):338\u2013341.","journal-title":"J Korean Med Sci"},{"issue":"3","key":"2288_CR14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5858\/2000-124-0446-TSMCWE","volume":"124","author":"AC Solomon","year":"2000","unstructured":"Solomon AC, Baloch ZW, Salhany KE, Mandel S, Weber RS, LiVolsi VA. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: mimic of Hodgkin disease in nodal metastases. Arch Pathol Lab Med. 2000;124(3):446\u2013449.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2288_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.anndiagpath.2003.09.002","volume":"7","author":"J Albores-Saavedra","year":"2003","unstructured":"Albores-Saavedra J, Gu X, Luna MA. Clear cells and thyroid transcription factor I reactivity in sclerosing mucoepidermoid carcinoma of the thyroid gland. Ann Diagn Pathol. 2003;7(6):348\u2013353.","journal-title":"Ann Diagn Pathol"},{"issue":"4","key":"2288_CR16","first-page":"660","volume":"46","author":"K Sharma","year":"2003","unstructured":"Sharma K, Nigam S, Khurana N, Chaturvedi KU. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid--a case report. Indian J Pathol Microbiol. 2003;46(4):660\u2013661.","journal-title":"Indian J Pathol Microbiol"},{"issue":"5","key":"2288_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/modpathol.3800021","volume":"17","author":"JL Hunt","year":"2004","unstructured":"Hunt JL, LiVolsi VA, Barnes EL. p63 expression in sclerosing mucoepidermoid carcinomas with eosinophilia arising in the thyroid. Mod Pathol. 2004;17(5):526\u2013529.","journal-title":"Mod Pathol"},{"key":"2288_CR18","first-page":"122","volume":"34","author":"\u00d6 Kanat","year":"2004","unstructured":"Kanat \u00d6, Evrensel T, Tolunay S, et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: Description of a case and review of the literature. Turkish Journal of Cancer 2004;34:122\u2013126.","journal-title":"Turkish Journal of Cancer"},{"issue":"1","key":"2288_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/0377-4929.40389","volume":"51","author":"S Das","year":"2008","unstructured":"Das S, Kalyani R. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid. Indian J Pathol Microbiol. 2008;51(1):34\u201336.","journal-title":"Indian J Pathol Microbiol"},{"issue":"3","key":"2288_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archotol.134.3.333","volume":"134","author":"W. D. Frazier","year":"2008","unstructured":"Frazier WD, Patel NP, Sullivan CA. Pathology quiz case 1. Sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE). Arch Otolaryngol Head Neck Surg. 2008;134(3):333, 335.","journal-title":"Archives of Otolaryngology - Head and Neck Surgery"},{"issue":"8","key":"2288_CR21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/000313481007600850","volume":"76","author":"PG Cal\u00f2","year":"2010","unstructured":"Cal\u00f2 PG, Maxia S, Lai ML, Nicolosi A, Ribuffo D. Sclerosing mucoepidermoid thyroid carcinoma requiring cervical reconstruction: a case report and review of the literature. Am Surg. 2010;76(8):918\u2013919.","journal-title":"Am Surg"},{"issue":"5","key":"2288_CR22","first-page":"5947","volume":"8","author":"CY Lai","year":"2015","unstructured":"Lai CY, Chao TC, Lin JD, Hsueh C. Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid gland in a male patient: a case report and literature review. Int J Clin Exp Pathol. 2015;8(5):5947\u20135951.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"2288_CR23","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/j.ciresp.2014.06.005","volume":"93","author":"R Orbeal","year":"2015","unstructured":"Orbeal R, Jimeno J, Monroy G, Badia F, Par\u00e9s D. [Sclerosing mucoepidermoid carcinoma of the thyroid gland with eosinophilia]. Cir Esp. 2015;93(10):e137\u2013138.","journal-title":"Cir Esp"},{"issue":"5","key":"2288_CR24","first-page":"44","volume":"75","author":"LS Selivanova","year":"2013","unstructured":"Selivanova LS, Tertychny\u012d AS. [Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland]. Arkh Patol. 2013;75(5):44\u201349.","journal-title":"Arkh Patol"},{"issue":"1","key":"2288_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/0970-9371.175511","volume":"33","author":"C Pantola","year":"2016","unstructured":"Pantola C, Kala S, Athar M, Thakur S. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: A cytological dilemma. J Cytol. 2016;33(1):37\u201339.","journal-title":"J Cytol"},{"issue":"7","key":"2288_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/dc.23914","volume":"46","author":"E Ames","year":"2018","unstructured":"Ames E, Campbell MJ, Afify A, Krane JF, Huang EC. Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroid. Diagn Cytopathol. 2018;46(7):632\u2013635.","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"2288_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1507\/endocrj.EJ17-0462","volume":"65","author":"M Hirokawa","year":"2018","unstructured":"Hirokawa M, Takada N, Abe H, et al. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia distinct from the salivary type. Endocr J. 2018;65(4):427\u2013436.","journal-title":"Endocr J"},{"issue":"2","key":"2288_CR28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/IJPM.IJPM_169_17","volume":"61","author":"AKA Raveendran Nair","year":"2018","unstructured":"Raveendran Nair AKA, George NA, Kumar R, Sreekumar A, Jayasree K. Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid gland: Not so indolent a neoplasm? Indian J Pathol Microbiol. 2018;61(2):242\u2013244.","journal-title":"Indian J Pathol Microbiol"},{"issue":"26","key":"2288_CR29","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364(26):2507\u201316.","journal-title":"N Engl J Med"},{"issue":"9839","key":"2288_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","volume":"380","author":"A Hauschild","year":"2012","unstructured":"Hauschild A, Grob JJ, Demidov LV, Jouary T, Gutzmer R, Millward M, et al. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet. 2012;380(9839):358\u201365.","journal-title":"Lancet"},{"key":"2288_CR31","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.12659\/MSM.910084","volume":"24","author":"H Song","year":"2018","unstructured":"Song H, Zhang J, Ning L, Zhang H, Chen D, Jiao X, et al. The MEK1\/2 inhibitor AZD6244 sensitizes BRAF-mutant thyroid cancer to vemurafenib. Med Sci Monit. 2018;24:3002\u201310.","journal-title":"Med Sci Monit"},{"issue":"1","key":"2288_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","volume":"36","author":"V Subbiah","year":"2018","unstructured":"Subbiah V, Kreitman RJ, Wainberg ZA, Cho JY, Schellens JHM, Soria JC, et al. Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer. J Clin Oncol. 2018;36(1):7\u201313.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2288-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2288-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2288-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T10:05:48Z","timestamp":1613297148000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2288-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2288"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2288-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"4 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional review board exemption obtained as case series only has two subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Institutional review board exemption obtained as case series only has two subjects. The copy of the exemption letter is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Welch reports receiving honoraria from AbbVie for lectures. All other authors have no disclosures or competing financial interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"385"}}